Cleared Traditional

K214065 - ROSA ONE Brain application

K214065 is an FDA 510(k) clearance for ROSA ONE Brain application, manufactured by Medtech S.A.S. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 128-day FDA review.

K214065 · Medtech S.A.S · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2022
Decision
128d
Days
Class 2
Risk

K214065 is an FDA 510(k) clearance for the ROSA ONE Brain application. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Medtech S.A.S (Mauguio, FR). The FDA issued a Cleared decision on May 4, 2022 after a review of 128 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtech S.A.S devices

FDA 510(k) Submission Details - K214065

510(k) Number K214065 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2021
Decision Date May 04, 2022
Days to Decision 128 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 148d · This submission: 128d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 258
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K214065.
Cranial EM System
K213989 · Brainlab AG · Sep 2022
Disposable Brain Biopsy Needle 2.0
K220897 · PAJUNK GmbH Medizintechnologie · Aug 2022
Synergy Cranial v2.2.9, StealthStation Cranial v3.1.4
K221087 · Medtronic Navigation, Inc. · Jun 2022
ClearPoint Array System (version 1.1)
K214040 · ClearPoint Neuro, Inc. · Apr 2022
visor2 system
K210109 · Eemagine Medical Imaging Solutions GmbH · Apr 2022
StealthStation S8 Cranial v2.0
K212397 · Medtronic Navigation · Dec 2021